• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用单个可切除慢病毒干细胞盒从羊水细胞生成人β地中海贫血诱导多能干细胞。

Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.

作者信息

Fan Yong, Luo Yumei, Chen Xinjie, Li Qing, Sun Xiaofang

机构信息

Key Laboratory for Major Obstetric Diseases of Guangdong Province,The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China.

出版信息

J Reprod Dev. 2012;58(4):404-9. doi: 10.1262/jrd.2011-046. Epub 2012 Apr 13.

DOI:10.1262/jrd.2011-046
PMID:22498813
Abstract

Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a powerful tool for biomedical research and may have a wide range of applications in cell and gene therapy. However, the safety issues and the low efficiency associated with generating human iPSCs have limited their usage in clinical settings. The cell type used to create iPSCs can significantly influence the reprogramming efficiency and kinetics. Here, we show that amniotic fluid cells from the prenatal diagnosis of a β-thalassemia patient can be efficiently reprogrammed using a doxycycline (DOX)-inducible humanized version of the single lentiviral "stem cell cassette" vector flanked by loxP sites, which can be excised with Cre recombinase. We also demonstrated that the patient-derived iPSCs can be characterized based on the expression of pluripotency markers, and they can be differentiated into various somatic cell types in vitro and in vivo. Moreover, microarray analysis demonstrates a high correlation coefficient between human β-thalassemia iPS cells and human embryonic stem (hES) cells but a low correlation coefficient between human β-thalassemia amniotic fluid cells and human β-thalassemia iPS cells. Our data suggest that amniotic fluid cells may be an ideal human somatic cell resource for rapid and efficient generation of patient-specific iPS cells.

摘要

源自患者体细胞的诱导多能干细胞(iPSC)是生物医学研究的有力工具,在细胞和基因治疗中可能有广泛应用。然而,与生成人类iPSC相关的安全问题和低效率限制了它们在临床环境中的使用。用于创建iPSC的细胞类型可显著影响重编程效率和动力学。在此,我们表明,使用由loxP位点侧翼的强力霉素(DOX)诱导的人源化单慢病毒“干细胞盒”载体,可高效重编程来自一名β地中海贫血患者产前诊断的羊水细胞,该载体可用Cre重组酶切除。我们还证明,源自患者的iPSC可根据多能性标志物的表达进行表征,并且它们可在体外和体内分化为各种体细胞类型。此外,微阵列分析表明,人类β地中海贫血iPS细胞与人类胚胎干细胞(hES)之间的相关系数高,但人类β地中海贫血羊水细胞与人类β地中海贫血iPS细胞之间的相关系数低。我们的数据表明,羊水细胞可能是快速高效生成患者特异性iPS细胞的理想人类体细胞资源。

相似文献

1
Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.利用单个可切除慢病毒干细胞盒从羊水细胞生成人β地中海贫血诱导多能干细胞。
J Reprod Dev. 2012;58(4):404-9. doi: 10.1262/jrd.2011-046. Epub 2012 Apr 13.
2
Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic Diseases.从受单基因疾病影响胎儿的胚外组织中生成人类诱导多能干细胞。
Cell Reprogram. 2015 Aug;17(4):275-87. doi: 10.1089/cell.2015.0003.
3
Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.人羊膜来源细胞中的多能性可以被快速且高效地诱导。
Hum Mol Genet. 2009 Nov 15;18(22):4340-9. doi: 10.1093/hmg/ddp386. Epub 2009 Aug 13.
4
Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.同一移植β-地中海贫血症患者来源的诱导多能干细胞和成人造血干细胞中珠蛋白慢病毒转导的平行评估。
Stem Cells. 2013 Sep;31(9):1785-94. doi: 10.1002/stem.1436.
5
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.用于定制化胰岛再生的患者来源诱导多能干细胞后代的无瘤移植
Stem Cells Transl Med. 2016 May;5(5):694-702. doi: 10.5966/sctm.2015-0017. Epub 2016 Mar 17.
6
Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.从β地中海贫血成纤维细胞生成的原始诱导多能干细胞可通过CRISPR/Cas9进行高效基因校正。
Stem Cells Transl Med. 2016 Jan;5(1):8-19. doi: 10.5966/sctm.2015-0157. Epub 2015 Dec 16.
7
Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.利用可切除的慢病毒系统生成无转基因的小鼠诱导多能干细胞。
Exp Cell Res. 2014 Apr 1;322(2):335-44. doi: 10.1016/j.yexcr.2014.02.006. Epub 2014 Feb 18.
8
Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS.人羊水干细胞在妊娠中期早期具有更好的潜能,并且可以被重编程为诱导多能干细胞。
Taiwan J Obstet Gynecol. 2017 Dec;56(6):770-774. doi: 10.1016/j.tjog.2017.10.012.
9
Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.
Hemoglobin. 2017 May;41(3):198-202. doi: 10.1080/03630269.2017.1353523. Epub 2017 Aug 24.
10
The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.CRISPR/Cas9 与 iPSC 技术在小鼠人类β-地中海贫血症基因治疗中的联合应用。
Sci Rep. 2016 Sep 1;6:32463. doi: 10.1038/srep32463.

引用本文的文献

1
Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.组织受限干细胞作为高效生成多能干细胞的起始细胞来源:概述。
Adv Exp Med Biol. 2022;1376:151-180. doi: 10.1007/5584_2021_660.
2
The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice.β-地中海贫血症患者基因校正诱导多能干细胞在非清髓性β-地中海贫血症小鼠中的安全性和有效性。
Stem Cell Res Ther. 2020 Jul 16;11(1):288. doi: 10.1186/s13287-020-01765-w.
3
Modeling blood diseases with human induced pluripotent stem cells.
利用人诱导多能干细胞进行血液疾病建模。
Dis Model Mech. 2019 Jun 4;12(6):dmm039321. doi: 10.1242/dmm.039321.
4
The Impact of Epigenetic Signatures on Amniotic Fluid Stem Cell Fate.表观遗传特征对羊水干细胞命运的影响。
Stem Cells Int. 2018 Nov 25;2018:4274518. doi: 10.1155/2018/4274518. eCollection 2018.
5
Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases.羊水干细胞模型:填补人类遗传疾病知识空白的工具。
Brain Circ. 2017 Jul-Sep;3(3):167-174. doi: 10.4103/bc.bc_23_17. Epub 2017 Oct 12.
6
The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.利用转座子系统从小鼠羊水细胞中产生多能干细胞。
J Vis Exp. 2017 Feb 28(120):54598. doi: 10.3791/54598.
7
Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.通过修饰的 U7 snRNA 增强地中海贫血 IVS2-654 诱导多能干细胞衍生的红细胞中β-珠蛋白基因的表达。
Stem Cells Transl Med. 2017 Apr;6(4):1059-1069. doi: 10.1002/sctm.16-0121. Epub 2017 Feb 18.
8
Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.简明综述:精准医学时代的诱导多能干细胞研究
Stem Cells. 2017 Mar;35(3):545-550. doi: 10.1002/stem.2570. Epub 2017 Feb 5.
9
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia.β地中海贫血的基态幼稚多能干细胞与CRISPR/Cas9基因校正
Stem Cell Investig. 2016 Oct 25;3:66. doi: 10.21037/sci.2016.09.21. eCollection 2016.
10
Human induced pluripotent stem cells for monogenic disease modelling and therapy.用于单基因疾病建模与治疗的人类诱导多能干细胞。
World J Stem Cells. 2016 Apr 26;8(4):118-35. doi: 10.4252/wjsc.v8.i4.118.